Latest stories on VNDA
Vanda Shareholders Approve Directors, Auditor and Compensation Plans
TipRanks50 · neutralgeneral
Vanda Pharmaceuticals Inc. (VNDA) files 8-K
SEC 8-K50 · neutralgeneral
Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis
PR Newswire61 · neutralproduct/pr
VNDA: [Form 4] Vanda Pharmaceuticals Inc. Insider Trading Activity
StockTitan SEC50 · neutralgeneral
Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences
PR Newswire50 · neutralgeneral
Vanda (VNDA) Q1 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results
PR Newswire67 · bullishearnings